DDrare: Database of Drug Development for Rare Diseases

Human neural stem cells (DrugBank: -)

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1
13	多発性硬化症／視神経脊髄炎	1

2. 筋萎縮性側索硬化症　［臨床試験数：508，薬物数：530（DrugBank：146），標的遺伝子数：170，標的パスウェイ数：221］

Searched query = "Amyotrophic lateral sclerosis", "ALS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 508 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01640067 (ClinicalTrials.gov)	December 2011	9/7/2012	Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)	Intra-spinal Cord Delivery of Human Neural Stem Cells in ALS Patients: Proposal for a Phase I Study/ Trapianto Intramidollare di Cellule Staminali Neurali Umane Come Terapia Putativa Per la SLA: Proposta di un Trial Clinico di Fase I	Amyotrophic Lateral Sclerosis	Biological: Human Neural Stem Cells	Azienda Ospedaliera Santa Maria, Terni, Italy	Azienda Ospedaliero Universitaria Maggiore della Carita;Università di Padova Italy	Completed	20 Years	75 Years	Both	18	Phase 1	Italy

13. 多発性硬化症／視神経脊髄炎　［臨床試験数：3,050，薬物数：2,147（DrugBank：348），標的遺伝子数：244，標的パスウェイ数：228］

Searched query = "Multiple sclerosis/Neuromyelitis optica", "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 3,050 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03282760 (ClinicalTrials.gov)	September 9, 2017	9/8/2017	Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients	A Phase I Multicenter Study of Allogenic, Intracerebroventricular Human Neural Stem Cells Transplantation for the Experimental Treatment of Secondary Progressive Multiple Sclerosis Patients	Secondary-progressive Multiple Sclerosis	Biological: Human Neural Stem Cells	Casa Sollievo della Sofferenza IRCCS	Associazione Revert ONLUS;Neurocenter of Southern Switzerland;Fondazione Cellule Staminali	Active, not recruiting	18 Years	60 Years	All	24	Phase 1	Italy;Switzerland